GlassScriptPhysician profile
Scott Barbuto
NPI 1447677604
$2,482.99
in general payments reported to CMS, 2019-2025
5 companies · $1,994 in 2025
The $1,994 reported for 2025 was more than what 93% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.89 · 2022: $109 · 2023: $242 · 2024: $89.72 · 2025: $1,994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,270 · Food and Beverage: $1,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,270.00 |
| Food and Beverage | $1,055.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $1,678.90 | 2025 | Skyclarys, Spinraza |
| Abbvie INC. | $505.50 | 2022-2025 | Botox |
| Medtronic, INC. | $200.84 | 2024-2025 | Intellis Adaptivestim, Synchromedii |
| Allergan, INC. | $73.16 | 2021-2022 | |
| Depuy Synthes Sales INC. | $24.59 | 2025 | Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Barbuto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.